{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:25:52Z","timestamp":1782451552063,"version":"3.54.5"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>In recent years, vitamin D has become the protagonist in many studies. From cardiology to oncology the spotlight was on this vitamin. While in the past it was considered for its important role in phospho-calcium metabolism and skeletal disorders; today by studying it better, thousands of scenarios and facets have opened up on this vitamin which is actually a hormone in all respects. There are authoritative studies that demonstrate its activity <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> on: carcinogenesis, inflammation, autoimmunity and endocrinopathies. Its role has been studied in type 1 and type 2 diabetes mellitus, in Hashimoto or Graves\u2019 thyroiditis and even in adrenal gland diseases. In fact, there are several studies that demonstrate the possible correlations between vitamin D and: Addison\u2019s disease, Cushing disease, hyperaldosteronism or adrenocortical tumors. Moreover, this fascinating hormone and adrenal gland even seem to be deeply connected by common genetic pathways. This review aimed to analyze the works that have tried to study the possible influence of vitamin D on adrenal diseases. In this review we analyze the works that have tried to study the possible influence of vita-min D on adrenal disease.<\/jats:p>","DOI":"10.3389\/fendo.2022.1001065","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T07:28:46Z","timestamp":1665646126000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Vitamin D and adrenal gland: Myth or reality? A systematic review"],"prefix":"10.3389","volume":"13","author":[{"given":"Antonella","family":"Al Refaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Baldassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gonnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Caffarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"B1","article-title":"Autocrine and paracrine actions of vitamin d","volume":"31","author":"Morris","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41590-021-01080-3","article-title":"Autocrine vitamin d signaling switches off pro-inflammatory programs of TH1 cells","volume":"23","author":"Chauss","year":"2022","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2310\/JIM.0b013e31821b8755","article-title":"Vitamin d, and the immune system","volume":"59","author":"Aranow","year":"2011","journal-title":"J Investig Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin d, metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-012-0430-5","article-title":"Vitamin d metabolism, functions, and needs: from science to health claims","volume":"52","author":"Battault","year":"2013","journal-title":"Eur J Nutr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-016-9405-9","article-title":"Does vitamin d play a role in autoimmune endocrine disorders? a proof of concept","volume":"18","author":"Altieri","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00204-016-1804-x","article-title":"Vitamin d and chronic diseases: the current state of the art","volume":"91","author":"Muscogiuri","year":"2017","journal-title":"Arch Toxicol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.3390\/nu5103993","article-title":"Molecular link between vitamin d and cancer prevention","volume":"5","author":"Moukayed","year":"2013","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2757","article-title":"Clinical review: Do glucocorticosteroids alter vitamin d status? a systematic review with meta-analyses of observational studies","volume":"97","author":"Davidson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1600","article-title":"Association of glucocor-ticoid use and low 25- hydroxyvitamin d levels: Results from the national health and nutrition examination survey (NHANES): 2001\u20132006","volume":"96","author":"Skversky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2010.03.081","article-title":"Glucocorticoid regulation of the vitamin d receptor","volume":"121","author":"Hidalgo","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.244061","article-title":"Dexamethasone enhances 1\u03b1,25 dihydroxyvitamin D3 effects by increasing vitamin d receptor transcription","volume":"286","author":"Hidalgo","year":"2011","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107304","article-title":"Effects of cortisone administration on the metabolism and localization of 25-hydroxycholecalciferol in the rat","volume":"52","author":"Favus","year":"1973","journal-title":"J Clin Investig"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.33.345","article-title":"Impaired mineral metabolism in cushing\u2019s syndrome:Parathyroid function, vitamin d metabolites and osteopenia","volume":"33","author":"Kugai","year":"1986","journal-title":"Endocrinol Jpn"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109902","article-title":"Production, degradation, and circulating levels of 1,25- dihydroxyvitamin d in health and in chronic glucocorticoid excess","volume":"66","author":"Seeman","year":"1980","journal-title":"J Clin Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/nu1312432913","article-title":"Assessment of vitamin d metabolism in patients with cushing's disease in response to 150,000 IU cholecalciferol treatment","volume":"13","author":"Povaliaeva","year":"2021","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/nu1405097314","article-title":"Vitamin d deficiency in cushing\u2019s disease: Before and after its supplementation","volume":"14","author":"Guarnotta","year":"2022","journal-title":"Nutrients"},{"key":"B18","first-page":"399","article-title":"Serum 25-hydroxyvitamin d concentration in patients receiving chronic corticosteroid therapy","volume":"90","author":"Hahn","year":"1977","journal-title":"J Lab Clin Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb02706.x","article-title":"Parathyroid hormone and 25-hydroxy vitamin d levels in glucocorticoid treated patients","volume":"12","author":"Slovik","year":"1980","journal-title":"Clin Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-6-981","article-title":"Skeletal metabolism and body composition in cushing's syndrome","volume":"39","author":"Aloia","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","article-title":"Adrenal cancer. 2021","volume-title":"StatPearls","author":"Torti","year":"2022"},{"key":"B22","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of endocrinology clinical practice guide-lines on the management of adrenocortical carcinoma in adults, in collaboration with the European network for the study of adrenal tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00058","article-title":"Vitamin d and cancer","volume":"3","author":"Vuolo","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin d supplements and prevention of cancer and cardiovascular disease","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz059","article-title":"Vitamin d supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials","volume":"30","author":"Keum","year":"2019","journal-title":"Ann Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4673","article-title":"Association between vitamin d supplementation and mortality: systematic review and meta-analysis","volume":"366","author":"Zhang","year":"2019","journal-title":"BMJ"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2018.12.085","article-title":"Vitamin d and breast cancer: A systematic review and meta-analysis of observational studies","volume":"30","author":"Hossain","year":"2019","journal-title":"Clin Nutr ESPEN"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v6.i11.430","article-title":"Vitamin d and colon cancer","volume":"6","author":"Klampfer","year":"2014","journal-title":"World J Gastroint Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.581597","article-title":"Vitamin d status and survival in stage II-III colorectal cancer","volume":"17","author":"Bao","year":"2020","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2018.07.002","article-title":"Mechanisms of action of vitamin d in colon cancer","volume":"185","author":"Ferrer-Mayorga","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsbmb.2013.11.008","article-title":"1\u03b1,25-dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin d receptor against adrenocortical cancer","volume":"140","author":"Pilon","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/375349","article-title":"Methylation status of vitamin d receptor gene promoter in benign and malignant adrenal tumors","volume":"2015","author":"Pilon","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01127-1","article-title":"The effects of mitotane and 1\u03b1,25-dihydroxyvitamin D3 on wnt\/beta-catenin signaling in human adrenocortical carcinoma cells","volume":"43","author":"Rubin","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0879","article-title":"Vitamin d receptor hypermethylation as a biomarker for pediatric adrenocortical tumors","volume":"186","author":"Bueno","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.18761","article-title":"Primary aldosteronism: Where are we now? where to from here","volume":"79","author":"Funder","year":"2022","journal-title":"Hypertension"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","author":"Stowasser","year":"2009","journal-title":"J Clin Endocrinol Meta"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijchy.2020.100029","article-title":"The 2020 Italian society of arterial hypertension (SIIA) practical guidelines for the management of primary aldosteronism","volume":"5","author":"Rossi","year":"2020","journal-title":"Int J Cardiol Hypertens"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015985","article-title":"Cardiovascular risk in primary aldosteronism: A systematic review and meta-analysis","volume":"98","author":"Wu","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI15219","article-title":"1,25-dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","article-title":"Plasma 25-hydroxyvitamin d and regulation of the renin-angiotensin system in humans","volume":"55","author":"Forman","year":"2010","journal-title":"Hypertension"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2010.04.009","article-title":"1alpha,25-dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells","volume":"1801","author":"Lundqvist","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2183","article-title":"Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study","volume":"97","author":"Pilz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0b013e32834f0451","article-title":"Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism","volume":"30","author":"Maniero","year":"2012","journal-title":"J Hypertens"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082309","article-title":"Vitamin d receptor, an important transcription factor associated with aldosterone-producing adenoma","volume":"8","author":"Bi","year":"2013","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2399-1","article-title":"Bone health and aldosterone excess","volume":"24","author":"Ceccoli","year":"2013","journal-title":"Osteop Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/836529","article-title":"Bone and mineral metabolism in patients with primary aldosteronism","volume":"2014","author":"Petramala","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpv146","article-title":"PTH is a promising auxiliary index for the clinical diagnosis of aldosterone-producing adenoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Am J Hypertens"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12825","article-title":"Effects of vitamin d supplementation on plasma aldosterone and renin-a randomized placebo- controlled trial","volume":"18","author":"Gr\u00fcbler","year":"2016","journal-title":"J Clin Hypertens"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14177","article-title":"The effect of vitamin d treatment on clinical and biochemical outcomes of primary aldosteronism","volume":"92","author":"Ismail","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MED.0000000000000062","article-title":"Interactions between adrenal-regulatory and calcium-regulatory hormones in human health","volume":"21","author":"Brown","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186483","article-title":"Vitamin d and cardiovascular disease, with emphasis on hypertension, atherosclerosis, and heart failure","volume":"21","author":"Latic","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70113-5","article-title":"Association of vitamin d status with arterial blood pressure and hypertension risk: a mendelian randomisation study","volume":"2","author":"Vimaleswaran","year":"2014","journal-title":"Lancet Diabe Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.01.019","article-title":"The effect of vitamin d on aldosterone and health status in patients with heart failure","volume":"20","author":"Boxer","year":"2014","journal-title":"J Card Fail"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5015417","article-title":"Effects of vitamin d supplementation on renin and aldosterone concentrations in patients with advanced heart failure: The EVITA trial","volume":"2018","author":"Zittermann","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0359-3","article-title":"Vitamin d supplementation: a novel therapy for aldosteronism","volume":"16","author":"Rossi","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/EJE-17-0128","article-title":"Mechanisms in endocrinology: Update on pathogenesis of primary adrenal insufficiency: beyond steroid enzyme deficiency and autoimmune adrenal destruction","volume":"177","author":"Fl\u00fcck","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2017.07.026","article-title":"Vitamin d effects on monocytes' CCL-2, IL6 and CD14 transcription in addison's disease and HLA susceptibility","volume":"177","author":"Kraus","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470635","article-title":"Vitamin d receptor genotype is associated with addison's disease","volume":"147","author":"Pani","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1241206","article-title":"Association of the CYP27B1 c(-1260)A polymorphism with autoimmune addison's disease","volume":"118","author":"Fichna","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1510193","article-title":"A promoter polymorphism of the CYP27B1 gene is associated with addison's disease, hashimoto's thyroiditis, graves' disease and type 1 diabetes mellitus in germans","volume":"151","author":"Lopez","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1677\/jme.1.01760","article-title":"A haplotype of the CYP27B1 promoter is associated with autoimmune addison's disease but not with graves' disease in a UK population","volume":"34","author":"Jennings","year":"2005","journal-title":"J Mol Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-171","article-title":"Hospital admissions for vitamin d related conditions and subsequent immune-mediated disease: record-linkage studies","volume":"11","author":"Ramagopalan","year":"2013","journal-title":"BMC Med"},{"key":"B66","article-title":"Vitamin d deficiency and adrenal function in critically ill children","volume":"98","author":"Korwutthikulrangsri","year":"2015","journal-title":"J Med Assoc Thai"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2392","article-title":"Impact of month of birth on the risk of development of autoimmune addison's disease","volume":"101","author":"Pazderska","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1126","article-title":"The relationship between vitamin d status and adrenal insufficiency in critically ill children","volume":"98","author":"McNally","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nut.2017.10.021","article-title":"High-dose vitamin d in addison's disease regulates T-cells and monocytes: A pilot trial","volume":"49","author":"Penna-Martinez","year":"2018","journal-title":"Nutrition"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.70.AEP1023","article-title":"Itamin d status and its associations with clinical and laboratory parameters in patients with addison\u2019s disease","volume":"70","author":"Zawadzka","year":"2020","journal-title":"Endocr Abst"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1001065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T07:28:54Z","timestamp":1665646134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1001065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":70,"alternative-id":["10.3389\/fendo.2022.1001065"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1001065","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"article-number":"1001065"}}